Sarah Hanigan, PharmD, BCPS (AQ-Cardiology), BCCP

Clinical Specialist in Cardiology/Anticoagulation
Clinical Assistant Professor of Pharmacy
Rotation(s) Offered: General Cardiology, Cardiac Critical Care, Advanced Heart Failure/Transplant


Clinical Specialist in Cardiology and Anticoagulation providing patient care for general cardiology, cardiac critical care and advanced heart failure/transplant patients. Lead pharmacist for the Inpatient Pharmacist-assisted Anticoagulation Service, Secretary of the Anticoagulation Subcommittee for P&T, and Adjunct Clinical Assistant Professor for the University of Michigan College of Pharmacy 

Pharmacy School Attended: Drake University (2010)

Other Training: 

  • PGY1 Pharmacy: The Nebraska Medical Center (2011)
  • PGY2 Cardiology: The University of Illinois at Chicago (2012)

Areas of Interest

Anticoagulation, Heart failure/transplant

Published Articles or Reviews

  • Stuart M, Johnson L, Hanigan S, Pipe SW, Li SH. Anti-factor IIa (FIIa) heparin assay for patients on direct factor Xa (FXa) inhibitors. J Thombo Haemost. 2020 Jul;18(7):1653-1660
  • Hanigan S, Das J, Pogue K, Barnes GD, Dorsch MP. The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding. J Thromb Thrombolysis 2020 May;49(4):636-643
  • Hanigan S, Barnes GD. Managing anticoagulant-related bleeding in patients with venous thromboembolism. Oct 8, 2019
  • Adie S, Bitar A, Hanigan S, Pogue K, Koelling T, Dorsch M. Real-World prevalence of adverse events after initiating sacubitril/valsartan compared with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in systolic heart failure. J Card Fail. 2019 May;25(5):412-413
  • Grant PJ, Courey AJ, Hanigan S, Kolbe MS, Kronick SL, Obi A, Seagull FJ, Sood SL, Wakefield TW, Williams DM, Froehlich JB, Fontana R, Haft JW, Sonnenday CJ. Special Topics in Venous Thromboembolism [Internet]. Ann Arbor (MI): Michigan Medicine University of Michigan; 2019 Feb. 
  • Early CR, Park JM, DorschMP, Pogue KT, Hanigan S. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile. Transpl Infect Dis. 2016 Oct;18(5):714-720.
  • Ha NB, Yang K, Hanigan S, Kurtz B, Dorsch MP, Mak H, Nagel J. Impact ofa guideline for the management of antimicrobial/warfarin interactions in the inpatient setting and across transition of care. Ann Pharmacother. 2016 Sep;50(9):734-40.
  • Kaminsky BM, Pogue KT, Hanigan S, Koelling TM, Dorsch MP. Effects of total dose infusionof iron intravenously in patients with acute heart failure and anemia (hemoglobin < 13 g/dl). Am J Cardiol. 2016 Jun;117(12):1942-6.
  • Hanigan Sand DiDomenico RJ. Emerging therapies for acute and chronic heart failure: hope or hype? J Pharm Pract. 2016 Feb;29(1):46-57.